Bruker Vs. Sarepta Therapeutics Industry Stock Comparison

Sell

22

BRKR
Bruker

Last Price:

$38.76

Seasonality Move:

2.47%

Buy

52

SRPT
Sarepta Therapeutics

Last Price:

$51.00

Seasonality Move:

12.51%

Sell

22

Bruker (BRKR) is a Sell

Is Bruker a Buy, Sell or Hold?

The current Bruker [BRKR] share price is $38.76. The Score for BRKR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
BRKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

52

Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $51.03. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRKR Stock Price Chart

What is Bruker's stock price today?

The Bruker share price today is $38.76

The current trend is relatively stagnant and BRKR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $51.03

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

BRKR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.68	Sell
Relative Strength Index (14 RSI):	40.1	Sell
Chaikin Money Flow:	2187962	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(39.24 - 46.1)	Sell
Bollinger Bands (100):	(45.58 - 59.46)	Sell

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-12.25	Sell
Relative Strength Index (14 RSI):	26.54	Sell
Chaikin Money Flow:	1747021	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(55.57 - 90.55)	Sell
Bollinger Bands (100):	(83.88 - 128.16)	Sell

BRKR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	38.54	Buy
20-day SMA:	41.84	Sell
50-day SMA:	47.27	Sell
200-day SMA:	58.09	Sell
8-day EMA:	39.14	Sell
20-day EMA:	41.43	Sell
50-day EMA:	46.23	Sell
200-day EMA:	56.92	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	54.28	Sell
20-day SMA:	66.37	Sell
50-day SMA:	91.18	Sell
200-day SMA:	120.65	Sell
8-day EMA:	55.11	Sell
20-day EMA:	66.27	Sell
50-day EMA:	84.86	Sell
200-day EMA:	110.43	Sell

Bruker Earnings Growth & BRKR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.28 per share, and an increase next year of $0.41 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $4.38 per share, and an increase next year of $5.87 per share.

Bruker Technical Analysis

	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7	Apr 8	Apr 9	Apr 10	Apr 11
	Mar		Apr
	31	01	02	03	04	07	08	09	10	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7	Apr 8	Apr 9	Apr 10	Apr 11
	Mar		Apr
	31	01	02	03	04	07	08	09	10	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):